Zenas BioPharma
Xiaodong Wang has extensive experience in the field of clinical pharmacology. Xiaodong is currently the Executive Director and Head of Clinical Pharmacology at Zenas BioPharma since May 2021. Prior to that, they worked at Sarepta Therapeutics as the Senior Director and Head of Clinical Pharmacology from 2018 to May 2021. From 2014 to 2018, they held the position of Senior Director of Clinical Pharmacology at TESARO. Xiaodong Wang also worked as a Clinical Pharmacologist at Genentech from 2012 to 2014, and as a Senior Research Investigator in Clinical Pharmacology and Pharmacometrics at Bristol-Myers Squibb in Princeton, New Jersey from 2007 to 2012.
Xiaodong Wang holds a Doctor of Philosophy (Ph.D.) degree in Pharmacokinetics and Pharmacodynamics from the University at Buffalo.
This person is not in any offices
Zenas BioPharma
6 followers
Zenas BioPharma is a cross-border (China-USA-based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for patients in China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through its successful business development strategy.